Technology area: Biotechnology & Pharmaceuticals
7 pending office actions • 6 art units • 6 examiners • 0 of 7 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days
Inguran LLC has 7 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 6 distinct examiners and 6 distinct art units, indicating limited overlap in both examiner and technical assignment.
BARRON, SEAN C is the busiest examiner, with 2 pending matters. That small concentration may justify reviewing the examiner’s treatment for recurring issues, while the remaining matters require separate attention across their assigned examination settings.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (43%) |
| §102 only | 1 (14%) |
| Multi-statute (no §101) | 2 (29%) |
| No statute on record | 1 (14%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BARRON, SEAN C | 2 | 52.7% | +30.4% |
| RAHMAN, MD M | 1 | 92.4% | +11.9% |
| HALL, DEANNA K | 1 | 75.7% | +15.3% |
| DHAR, MATASHA | 1 | 43.5% | +44.8% |
| GODDARD, LAURA B | 1 | 50.8% | +13.6% |
| TURK, NEIL N | 1 | 51.0% | +44.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16859783 | METHODS AND COMPOSITIONS FOR DETERMINING THE PRESENCE OR ABSENCE OF DNA ABERRATIONS | BARRON, SEAN C | 30d |
| 16379456 | METHODS AND COMPOSITIONS FOR DETERMINING THE PRESENCE OR ABSENCE OF DNA ABERRATIONS | BARRON, SEAN C | 30d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17406747 | METHOD AND SYSTEM INCORPORATING BEAM SHAPING OPTICS AND BEAM STABILIZATION | TURK, NEIL N | 6d |
| 16859783 | METHODS AND COMPOSITIONS FOR DETERMINING THE PRESENCE OR ABSENCE OF DNA ABERRATIONS | BARRON, SEAN C | 30d |
| 16379456 | METHODS AND COMPOSITIONS FOR DETERMINING THE PRESENCE OR ABSENCE OF DNA ABERRATIONS | BARRON, SEAN C | 30d |
| 19067328 | SYSTEMS AND METHOD FOR CORRECTION OF POSITIONALLY DEPENDENT ELECTROMAGNETIC RADIATION DETECTED FROM OBJECTS WITHIN A FLUID COLUMN | RAHMAN, MD M | — |
| 18597579 | DEVICES AND METHODS FOR ARTIFICIAL INSEMINATION | HALL, DEANNA K | — |
| 17722174 | LOW SUGAR SPERM MEDIA AND COMPOSITIONS | DHAR, MATASHA | — |
| 17668910 | COMPOSITIONS AND METHODS FOR REDUCING AGGLUTINATION AND IMPROVING HEALTH OF SEX-SORTED SPERM CELLS | GODDARD, LAURA B | — |
| Art Unit | Apps |
|---|---|
| 1653 | 2 |
| 2877 | 1 |
| 3783 | 1 |
| 1632 | 1 |
| 1657 | 1 |
| 1798 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19067328 | SYSTEMS AND METHOD FOR CORRECTION OF POSITIONALLY DEPENDENT ELECTROMAGNETIC RADIATION DETECTED FROM OBJECTS WITHIN A FLUID COLUMN | RAHMAN, MD M | 2877 | Other | Non-Final OA | — | Pending | Feb 28, 2025 |
| 18597579 | DEVICES AND METHODS FOR ARTIFICIAL INSEMINATION | HALL, DEANNA K | 3783 | §102 | Non-Final OA | — | Pending | Mar 06, 2024 |
| 17722174 | LOW SUGAR SPERM MEDIA AND COMPOSITIONS | DHAR, MATASHA | 1632 | §103 | Final Rejection | — | Pending | Apr 15, 2022 |
| 17668910 | COMPOSITIONS AND METHODS FOR REDUCING AGGLUTINATION AND IMPROVING HEALTH OF SEX-SORTED SPERM CELLS | GODDARD, LAURA B | 1657 | §103 | Final Rejection | — | Pending | Feb 10, 2022 |
| 17406747 | METHOD AND SYSTEM INCORPORATING BEAM SHAPING OPTICS AND BEAM STABILIZATION | TURK, NEIL N | 1798 | §103 | Non-Final OA | 6d | Pending | Aug 19, 2021 |
| 16859783 | METHODS AND COMPOSITIONS FOR DETERMINING THE PRESENCE OR ABSENCE OF DNA ABERRATIONS | BARRON, SEAN C | 1653 | §102§103 | Final Rejection | 30d | Pending | Apr 27, 2020 |
| 16379456 | METHODS AND COMPOSITIONS FOR DETERMINING THE PRESENCE OR ABSENCE OF DNA ABERRATIONS | BARRON, SEAN C | 1653 | §102§103 | Final Rejection | 30d | Pending | Apr 09, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialInguran LLC has 7 pending office actions as of October 2026, spread across 6 art units and 6 examiners.
Sean C Barron has the most, with 2 of Inguran LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
